Oncotarget Prognostic Markers Identified in Ultra-Rare Adrenal Cancer Researchers demonstrated the overexpression of the protein APOBEC3B in adrenocortical carcinoma. They also identified the... read more January 26, 2022
Oncotarget Oncotarget’s Top 10 Most-Viewed Papers in 2021 Read the 10 most-viewed oncology-focussed papers on Oncotarget.com in 2021.—#10: Metformin and... read more January 21, 2022
Oncotarget Gene Mutations and Neoantigens in Head and Neck Tumors The aim of this exploratory study was to characterize the genomic and neoantigen changes in... read more January 13, 2022
Oncotarget Open-Access Oncotarget Shifts to Continuous Publishing As of 2022, the peer-reviewed and open-access journal Oncotarget has shifted to continuous... read more January 6, 2022
Oncotarget Can Purified Cholera Stop Obesity? In this 2019 study, researchers investigated the effects of purified elements of cholera toxin in... read more December 31, 2021
Oncotarget New Study: Biomarkers Linked to the Progression of Endometrial Cancer Researchers conducted a study to identify differentially regulated signaling pathways and genes related to endometrial... read more December 22, 2021
Oncotarget Table of Contents: Oncotarget’s Volume 12, Issue 26 Read short summaries of the latest oncology-focused research published in this week’s issue of... read more December 21, 2021
Oncotarget Could Metformin and Rapamycin Replace Maintenance Chemotherapy? Researchers explored metformin with or without rapamycin as maintenance therapy in patients with metastatic pancreatic... read more December 16, 2021
Oncotarget Lung Cancer Antigen Expression Characterized by Molecular Subtype In Oncotarget’s Volume 12, Issue 25, cover paper, researchers classified the various expression levels... read more December 8, 2021
Oncotarget Table of Contents: Oncotarget’s Volume 12, Issue 25 Read short summaries of the latest oncology-focused research published in this week’s issue of... read more December 7, 2021